23 Stocks Moving in Tuesday’s Pre-Market Session
Gainers
Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) rose 62.1% to $1.05 in pre-market trading as the company issued a clinical and corporate update.
Liquidia Names Roger Jeffs CEO
Liquidia Corporation (NASDAQ:LQDA) today announced Dr. Roger Jeffs has been appointed as Chief Executive Officer (CEO) effective January 3, 2022 and will continue as a director on the board. He succeeds Damian deGoa who
Stipulation Of Partial Judgment In Favor Of Liquidia Filed In Hatch-Waxman Litigation
MORRISVILLE, N.C., Dec. 29, 2021 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ:LQDA) announced today that United Therapeutics Corporation (UTC) has filed a stipulation of partial judgment with respect to U.S. Patent
91 Biggest Movers From Yesterday
Gainers
NuZee, Inc. (NASDAQ: NUZE) shares jumped 164.5% to settle at $5.29 on Thursday. NuZee manufacturing partner, Cuvee Coffee, reported an expansion into select Walmart stores nationwide.
Liquidia’s Inhaled Treprostinil Powder Scores Tentative FDA Approval For PAH
The FDA has granted tentative approval to Liquidia Corporation’s (NASDAQ:LQDA) Yutrepia (treprostinil) inhalation powder for pulmonary arterial hypertension (PAH) to improve exercise…
Attention Biotech Investors: Mark Your Calendar For November PDUFA Dates
The loaded Prescription Drug User Fee Act (PDUFA) calendar for October produced mixed outcomes.
PDUFA dates are key binary events for biotech stocks that can move the needle in a big way. These are the dates by which the Food and Drug Administration is required to announce its decision regarding approvability/non-approvability of drugs.
